• Quality of Life for the Global Patient

    In our world live 7.8 billion people. Pharma only focuses on cancer treatments for 1.6 billion people. How can the other 6.2 billion people hold no interest for pharma? Even from a commercial perspective, it is unwise to neglect these people. And don’t say that there is no profit possible in low- and middle-income countries. Pharma can turn a profit...

    READ MORE
  • How Lack of Accepted Standards Prevents Connected Health from Taking Off

    Lack of globally accepted standards in health data management hampers the advancement of Connected Health, which we hope, can give the world faster, cheaper, and more accessible preventive healthcare. With thousands and thousands of personal medical sensors available on the market, dozens of electronic health record systems used at hospitals,...

    READ MORE
  • Mechanical Thrombectomy – should we rethink how we treat stroke?

    Stroke is not a risk for older people exclusively. Across all types of stroke, we need to remember that a quarter of them occur in people under 65. 1  We know the combination of a decrease in deaths from stroke and an increase in actual stroke events means more people will survive and live with the impact of stroke. The burden of stroke is likely...

    READ MORE
  • Awareness, Education, Prevention and Government

    In September of this year, our group of international patient advocates and scholar-activists had a congress at the Royal Netherlands Academy of Arts and Sciences. We had several good discussions about prevention, breast cancer prevention, and early diagnostics and prevention of HPV-related cancers. Mostly, we discussed cervical cancer but learned...

    READ MORE
  • Andra Tutto Bene = Everything will be all right!

    Hello my dear readers,   Before I hit the road to Bonnie Scotland, where I will spend my holidays this year, I will share my thoughts with you.   I saw a great series on TV last week, which made me think.   It was about the beautiful Albert & Victoria museum in London. The museum curators prepared to open their doors again after lockdown, which...

    READ MORE
  • Connected Care and Utilisation of Patient Data

    Connecting care teams to patients can drive patient engagement and improve treatment processes that can assist cooperative care. HealthManagement.org interviewed Xavier Battle, head of Marketing and Sales for the Digital Health Business Line for Siemens Healthineers, about the importance and benefits of connected care, application of real-time data,...

    READ MORE
  • So Why am I Worrying Now? Thoughts from the UK on Pandemic Times

      My Dear Readers, Time is flying, and here I am again, sharing my thoughts as a registered nurse working during a very dramatic time.   The first half of the year of 2021 is over. If you reflect now, one can not comprehend of what has happened in the world during these last months. It is almost impossible. Where will one start and stop?...

    READ MORE
  • What About Post-Corona?

    Is there a time after COVID-19? Do you regularly hear the question of what we will do after COVID-19? Or what should we do? This is a strange question, because there will be no time after Coronavirus. Corona is an endemic virus, that is among us and does not go away. There is also no time after Influenza. Endemic viruses are here. We need to take...

    READ MORE
  • While perioperative care is optimized, patients die unmonitored in wards!

    There is a high demand for a comfortable, small and mobile solution for affordable blood pressure and vital sign monitoring in the general ward to improve patient safety and outcome, as mortality after surgery is a thousand times higher than intraoperative death. 1    CNSystems has enhanced its non-invasive CNAP® technology for perioperative...

    READ MORE
  • Patient’s Voice to Cancel Cancer: When Accountability Becomes Responsibility

    In the past decades something happened in healthcare that doesn’t benefit patients. Actually, it is what we patient advocates call ‘Dying is safer’. For some of the stakeholders in the medical industrial complex it is safer to let patients die than to act. We can think of experimental medicines for patients with an unmet medical need. Why not...

    READ MORE
Subscribe To The Executive Health Management Channel